A phase III concurrent chemoradiotherapy trial with cisplatin and paclitaxel or docetaxel or gemcitabine in unresectable non-small cell lung cancer: KASLC 0401

被引：0
|
作者：
In-Jae Oh
Kyu-Sik Kim
Young-Chul Kim
Hee-Jung Ban
Yong-Soo Kwon
Yu-Il Kim
Sung-Chul Lim
Woong-Ki Chung
Taek-Keun Nam
Joo-Young Song
Mee-Sun Yoon
Sung-Ja Ahn
机构：
[1] Chonnam National University Hwasun Hospital,Lung and Esophageal Cancer Clinic
[2] Chonnam National University,Department of Internal Medicine
[3] Chonnam National University,Department of Radiation Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2013年 / 72卷
关键词：
Non-small cell lung cancer; Concurrent chemoradiotherapy; Paclitaxel; Docetaxel; Gemcitabine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1247 / 1254
页数：7
相关论文
共 50 条
  • [21] Efficacy and toxicity of concomitant chemoradiotherapy with docetaxel and cisplatin in unresectable locally advanced stage non-small cell lung cancer
    Kaya, A. O.
    Buyukberber, S.
    Coskun, U.
    Yildiz, R.
    Yaman, E.
    Ozturk, B.
    Kalender, M. E.
    Orhan, O.
    Sevinc, A.
    Benekli, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 140 - 140
  • [22] Concomitant chemoradiotherapy with docetaxel and cisplatin followed by consolidation chemotherapy in locally advanced unresectable non-small cell lung cancer
    Eroglu, Celalettin
    Orhan, Okan
    Unal, Dilek
    Dogu, Gamze G.
    Karaca, Halit
    Dikilitas, Mustafa
    Ozturk, Ahmet
    Ozkan, Metin
    Kaplan, Bunyamin
    ANNALS OF THORACIC MEDICINE, 2013, 8 (02) : 109 - 115
  • [23] PHASE II TRIAL OF BIWEEKLY CHEMOTHERAPY WITH DOCETAXEL AND CISPLATIN IN HIGH RISK PATIENTS WITH UNRESECTABLE NON-SMALL CELL LUNG CANCER
    Lee, Gyeong-Won
    Go, Se-Il
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S588 - S588
  • [24] Phase II trial of gemcitabine and cisplatin sequentially administered in Asian patients with unresectable or metastatic non-small cell lung cancer
    Poon, D
    Foo, KF
    Chew, L
    Leong, SS
    Wee, J
    Tan, EH
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2006, 35 (01) : 33 - 37
  • [25] Multimodality treatment of unresectable stage III non-small cell lung cancer:: Interim analysis of a phase II trial with preoperative gemcitabine and concurrent radiotherapy
    Galetta, D
    Cesario, A
    Margaritora, S
    Porziella, V
    Piraino, A
    D'Angelillo, RM
    Gambacorta, MA
    Ramella, S
    Trodella, L
    Valente, S
    Corbo, GM
    Macis, G
    Mulè, A
    Cardaci, V
    Sterzi, S
    Granone, P
    Russo, P
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2006, 131 (02): : 314 - 321
  • [26] Phase II study of cisplatin, etoposide and concurrent radiation therapy with maintenance chemotherapy with cisplatin and gemcitabine for unresectable non-small cell lung cancer.
    Melzner, W
    Fink, TH
    Ficker, JH
    Sauer, R
    Strnad, V
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 688S - 688S
  • [27] Cisplatin, Gemcitabine and paclitaxel in advanced non-small cell lung cancer. A phase I study
    Comella, P
    Frasci, G
    Panza, N
    Lorusso, V
    Nicolella, GP
    Natale, M
    Manzione, L
    Bilancia, D
    Cioffi, R
    Maiorino, L
    Apicella, A
    Gravina, A
    Ruffolo, P
    De Rosa, V
    Comella, G
    ANNALS OF ONCOLOGY, 1998, 9 : 91 - 91
  • [28] Concurrent sintilimab with sequential chemoradiotherapy for unresectable, stage III non-small cell lung cancer: a retrospective study
    Tang, Shi
    Cong, Xiaofeng
    Zheng, Dan
    Chen, Chen
    Liu, Zengguang
    Gao, Jie
    Zhang, Huimin
    Zhang, Youhao
    Liu, Ziling
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [29] Sequential chemoradiotherapy versus concurrent chemoradiotherapy plus consolidation chemotherapy in unresectable stage III non-small cell lung cancer
    El-Shenshawy, H. M.
    Fathy, A.
    Eteba, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [30] A phase I trial of paclitaxel, carboplatin, and gemcitabine in advanced non-small cell lung cancer
    Kelly, K
    Prindiville, S
    Bunn, PA
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 74 - 74
12345